Strattera (Atomoxetine HCl) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health resources. Learn about atomoxetine (Strattera) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives. Strattera is a treatment for attention deficit hyperactivity disorder (ADHD) to help improve attention and reduce hyperactivity and impulsiveness. Strattera works by increasing levels of norepinephrine, a chemical messenger in the brain that is involved in hyperactivity and impulse control. Atomoxetine works in the brain to increase attention and decrease restlessness in people who are hyperactive, have problems with concentration, or are easily distracted. This medicine may be used as part of a treatment program that includes social, educational, and psychologic treatment. Overview: Atomoxetine is used to help with attention deficit and hyperactivity disorder (ADHD) by improving focus and reducing impulsivity and hyperactivity. It works by increasing a natural. Detailed dosage guidelines and administration information for Strattera (atomoxetine hydrochloride). Includes dose adjustments, warnings and precautions. Atomoxetine is a prescription medication that is used to treat attention-deficit hyperactivity disorder (ADHD). Symptoms of ADHD interfere can affect a person’s ability to function at school, work or in social settings. Symptoms can include: Hyperactivity is less common in adults. Strattera (atomoxetine) is a non-stimulant ADHD medication. Learn side effects, uses, dosages, and warnings. Strattera is approved for the treatment of attention- deficit/hyperactivity disorder (ADHD) in children aged 6 and older, teens, and adults.older, teens, and adults. Atomoxetine is manufactured, marketed, and sold in the United States as the hydrochloride salt (atomoxetine HCl) under the brand name Strattera by Eli Lilly and Company, the original patent -filing company and current U.S. patent owner.